HEADER TRANSFERASE 05-DEC-20 7KXW TITLE CRYSTAL STRUCTURE OF DCLK1-KD IN COMPLEX WITH DCLK1-IN-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE DCLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 3A,DOUBLECORTIN-LIKE COMPND 5 AND CAM KINASE-LIKE 1,DOUBLECORTIN-LIKE KINASE 1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: SERINE/THREONINE-PROTEIN KINASE DCLK1; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: DOUBLECORTIN DOMAIN-CONTAINING PROTEIN 3A,DOUBLECORTIN-LIKE COMPND 12 AND CAM KINASE-LIKE 1,DOUBLECORTIN-LIKE KINASE 1; COMPND 13 EC: 2.7.11.1; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DCLK1, DCAMKL1, DCDC3A, KIAA0369; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCOLD; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: DCLK1, DCAMKL1, DCDC3A, KIAA0369; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PCOLD KEYWDS KINASE, DOUBLECORTIN-LIKE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR O.PATEL,I.LUCET REVDAT 3 18-OCT-23 7KXW 1 REMARK REVDAT 2 13-OCT-21 7KXW 1 JRNL REVDAT 1 22-SEP-21 7KXW 0 JRNL AUTH O.PATEL,M.J.ROY,A.KROPP,J.M.HARDY,W.DAI,I.S.LUCET JRNL TITL STRUCTURAL BASIS FOR SMALL MOLECULE TARGETING OF JRNL TITL 2 DOUBLECORTIN LIKE KINASE 1 WITH DCLK1-IN-1. JRNL REF COMMUN BIOL V. 4 1105 2021 JRNL REFN ESSN 2399-3642 JRNL PMID 34545159 JRNL DOI 10.1038/S42003-021-02631-Y REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 11189 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 566 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.2880 - 4.7638 1.00 2757 133 0.1959 0.2316 REMARK 3 2 4.7638 - 3.7819 1.00 2670 160 0.1816 0.2524 REMARK 3 3 3.7819 - 3.3040 1.00 2666 145 0.2096 0.2758 REMARK 3 4 3.3040 - 3.0020 0.95 2530 128 0.2439 0.3381 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 383 THROUGH 390 OR REMARK 3 RESID 392 THROUGH 393 OR (RESID 394 AND REMARK 3 (NAME N OR NAME CA OR NAME C OR NAME O OR REMARK 3 NAME CB )) OR RESID 395 THROUGH 413 OR REMARK 3 RESID 415 THROUGH 421 OR (RESID 422 AND REMARK 3 (NAME N OR NAME CA OR NAME C OR NAME O OR REMARK 3 NAME CB )) OR RESID 432 THROUGH 443 OR REMARK 3 (RESID 444 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 445 REMARK 3 THROUGH 481 OR (RESID 482 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 483 THROUGH 520 OR RESID 528 REMARK 3 THROUGH 604 OR RESID 606 THROUGH 1)) REMARK 3 SELECTION : (CHAIN B AND (RESID 383 THROUGH 390 OR REMARK 3 RESID 392 THROUGH 396 OR RESID 402 REMARK 3 THROUGH 404 OR (RESID 405 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 406 THROUGH 409 OR (RESID 410 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 411 THROUGH 413 REMARK 3 OR RESID 415 THROUGH 422 OR RESID 432 REMARK 3 THROUGH 433 OR (RESID 434 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 435 THROUGH 483 OR RESID 485 REMARK 3 THROUGH 520 OR RESID 528 THROUGH 604 OR REMARK 3 RESID 606 THROUGH 648 OR RESID 1)) REMARK 3 ATOM PAIRS NUMBER : 1458 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KXW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000253322. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11200 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 44.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.15600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.77500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 5JZJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG400, AMMONIUM SULFPHATE, HEPES, PH REMARK 280 7.25, EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.97500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.85700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.97500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.85700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 370 REMARK 465 SER A 371 REMARK 465 GLY A 372 REMARK 465 GLU A 373 REMARK 465 GLU A 374 REMARK 465 VAL A 375 REMARK 465 SER A 376 REMARK 465 GLU A 377 REMARK 465 GLU A 378 REMARK 465 GLY A 379 REMARK 465 PHE A 380 REMARK 465 GLN A 381 REMARK 465 GLY A 397 REMARK 465 ASP A 398 REMARK 465 GLY A 399 REMARK 465 ASN A 400 REMARK 465 PHE A 401 REMARK 465 LYS A 423 REMARK 465 SER A 424 REMARK 465 LYS A 425 REMARK 465 CYS A 426 REMARK 465 ARG A 427 REMARK 465 GLY A 428 REMARK 465 LYS A 429 REMARK 465 GLN A 523 REMARK 465 ASP A 524 REMARK 465 GLY A 525 REMARK 465 SER A 526 REMARK 465 LYS A 527 REMARK 465 GLY A 591 REMARK 465 ASP A 592 REMARK 465 ASP A 593 REMARK 465 ASP A 649 REMARK 465 GLY B 370 REMARK 465 SER B 371 REMARK 465 GLY B 372 REMARK 465 GLU B 373 REMARK 465 GLU B 374 REMARK 465 VAL B 375 REMARK 465 SER B 376 REMARK 465 GLU B 377 REMARK 465 GLU B 378 REMARK 465 GLY B 379 REMARK 465 PHE B 380 REMARK 465 GLN B 381 REMARK 465 GLY B 397 REMARK 465 ASP B 398 REMARK 465 GLY B 399 REMARK 465 ASN B 400 REMARK 465 CYS B 426 REMARK 465 ARG B 427 REMARK 465 GLY B 591 REMARK 465 ASP B 592 REMARK 465 ASP B 593 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 405 CG CD CE NZ REMARK 470 ARG A 410 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 434 CG CD OE1 NE2 REMARK 470 MET A 455 CG SD CE REMARK 470 ASN A 481 CG OD1 ND2 REMARK 470 ARG A 486 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 394 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 401 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 422 CG CD CE NZ REMARK 470 LYS B 425 CG CD CE NZ REMARK 470 LYS B 444 CG CD CE NZ REMARK 470 MET B 455 CG SD CE REMARK 470 ASN B 481 CG OD1 ND2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 ARG B 486 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 523 CG CD OE1 NE2 REMARK 470 ASP B 524 CG OD1 OD2 REMARK 470 LYS B 527 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 384 -61.60 -137.61 REMARK 500 ASN A 481 -62.85 71.67 REMARK 500 ASP A 511 51.85 -148.57 REMARK 500 ASP A 533 80.61 51.00 REMARK 500 PHE A 534 31.50 -90.52 REMARK 500 LEU A 628 43.51 -102.59 REMARK 500 GLU B 430 -70.47 -45.34 REMARK 500 ASN B 481 -68.40 72.28 REMARK 500 ARG B 510 15.30 57.70 REMARK 500 ASP B 511 51.53 -154.37 REMARK 500 ASP B 533 81.04 48.20 REMARK 500 LEU B 628 43.66 -101.34 REMARK 500 REMARK 500 REMARK: NULL DBREF 7KXW A 372 649 UNP O15075 DCLK1_HUMAN 372 649 DBREF 7KXW B 372 649 UNP O15075 DCLK1_HUMAN 372 649 SEQADV 7KXW GLY A 370 UNP O15075 EXPRESSION TAG SEQADV 7KXW SER A 371 UNP O15075 EXPRESSION TAG SEQADV 7KXW GLY B 370 UNP O15075 EXPRESSION TAG SEQADV 7KXW SER B 371 UNP O15075 EXPRESSION TAG SEQRES 1 A 280 GLY SER GLY GLU GLU VAL SER GLU GLU GLY PHE GLN ILE SEQRES 2 A 280 PRO ALA THR ILE THR GLU ARG TYR LYS VAL GLY ARG THR SEQRES 3 A 280 ILE GLY ASP GLY ASN PHE ALA VAL VAL LYS GLU CYS VAL SEQRES 4 A 280 GLU ARG SER THR ALA ARG GLU TYR ALA LEU LYS ILE ILE SEQRES 5 A 280 LYS LYS SER LYS CYS ARG GLY LYS GLU HIS MET ILE GLN SEQRES 6 A 280 ASN GLU VAL SER ILE LEU ARG ARG VAL LYS HIS PRO ASN SEQRES 7 A 280 ILE VAL LEU LEU ILE GLU GLU MET ASP VAL PRO THR GLU SEQRES 8 A 280 LEU TYR LEU VAL MET GLU LEU VAL LYS GLY GLY ASP LEU SEQRES 9 A 280 PHE ASP ALA ILE THR SER THR ASN LYS TYR TPO GLU ARG SEQRES 10 A 280 ASP ALA SER GLY MET LEU TYR ASN LEU ALA SER ALA ILE SEQRES 11 A 280 LYS TYR LEU HIS SER LEU ASN ILE VAL HIS ARG ASP ILE SEQRES 12 A 280 LYS PRO GLU ASN LEU LEU VAL TYR GLU HIS GLN ASP GLY SEQRES 13 A 280 SER LYS SER LEU LYS LEU GLY ASP PHE GLY LEU ALA THR SEQRES 14 A 280 ILE VAL ASP GLY PRO LEU TYR THR VAL CYS GLY THR PRO SEQRES 15 A 280 THR TYR VAL ALA PRO GLU ILE ILE ALA GLU THR GLY TYR SEQRES 16 A 280 GLY LEU LYS VAL ASP ILE TRP ALA ALA GLY VAL ILE THR SEQRES 17 A 280 TYR ILE LEU LEU CYS GLY PHE PRO PRO PHE ARG GLY SER SEQRES 18 A 280 GLY ASP ASP GLN GLU VAL LEU PHE ASP GLN ILE LEU MET SEQRES 19 A 280 GLY GLN VAL ASP PHE PRO SER PRO TYR TRP ASP ASN VAL SEQRES 20 A 280 SER ASP SER ALA LYS GLU LEU ILE THR MET MET LEU LEU SEQRES 21 A 280 VAL ASP VAL ASP GLN ARG PHE SER ALA VAL GLN VAL LEU SEQRES 22 A 280 GLU HIS PRO TRP VAL ASN ASP SEQRES 1 B 280 GLY SER GLY GLU GLU VAL SER GLU GLU GLY PHE GLN ILE SEQRES 2 B 280 PRO ALA THR ILE THR GLU ARG TYR LYS VAL GLY ARG THR SEQRES 3 B 280 ILE GLY ASP GLY ASN PHE ALA VAL VAL LYS GLU CYS VAL SEQRES 4 B 280 GLU ARG SER THR ALA ARG GLU TYR ALA LEU LYS ILE ILE SEQRES 5 B 280 LYS LYS SER LYS CYS ARG GLY LYS GLU HIS MET ILE GLN SEQRES 6 B 280 ASN GLU VAL SER ILE LEU ARG ARG VAL LYS HIS PRO ASN SEQRES 7 B 280 ILE VAL LEU LEU ILE GLU GLU MET ASP VAL PRO THR GLU SEQRES 8 B 280 LEU TYR LEU VAL MET GLU LEU VAL LYS GLY GLY ASP LEU SEQRES 9 B 280 PHE ASP ALA ILE THR SER THR ASN LYS TYR THR GLU ARG SEQRES 10 B 280 ASP ALA SER GLY MET LEU TYR ASN LEU ALA SER ALA ILE SEQRES 11 B 280 LYS TYR LEU HIS SER LEU ASN ILE VAL HIS ARG ASP ILE SEQRES 12 B 280 LYS PRO GLU ASN LEU LEU VAL TYR GLU HIS GLN ASP GLY SEQRES 13 B 280 SER LYS SER LEU LYS LEU GLY ASP PHE GLY LEU ALA THR SEQRES 14 B 280 ILE VAL ASP GLY PRO LEU TYR THR VAL CYS GLY THR PRO SEQRES 15 B 280 THR TYR VAL ALA PRO GLU ILE ILE ALA GLU THR GLY TYR SEQRES 16 B 280 GLY LEU LYS VAL ASP ILE TRP ALA ALA GLY VAL ILE THR SEQRES 17 B 280 TYR ILE LEU LEU CYS GLY PHE PRO PRO PHE ARG GLY SER SEQRES 18 B 280 GLY ASP ASP GLN GLU VAL LEU PHE ASP GLN ILE LEU MET SEQRES 19 B 280 GLY GLN VAL ASP PHE PRO SER PRO TYR TRP ASP ASN VAL SEQRES 20 B 280 SER ASP SER ALA LYS GLU LEU ILE THR MET MET LEU LEU SEQRES 21 B 280 VAL ASP VAL ASP GLN ARG PHE SER ALA VAL GLN VAL LEU SEQRES 22 B 280 GLU HIS PRO TRP VAL ASN ASP MODRES 7KXW TPO A 484 THR MODIFIED RESIDUE HET TPO A 484 11 HET XBD A 701 38 HET PEG A 702 7 HET XBD B 701 38 HET PG4 B 702 13 HETNAM TPO PHOSPHOTHREONINE HETNAM XBD 2-{[2-METHOXY-4-(4-METHYLPIPERAZIN-1-YL)PHENYL]AMINO}- HETNAM 2 XBD 11-METHYL-5-(2,2,2-TRIFLUOROETHYL)-5,11-DIHYDRO-6H- HETNAM 3 XBD PYRIMIDO[4,5-B][1,4]BENZODIAZEPIN-6-ONE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PG4 TETRAETHYLENE GLYCOL HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 XBD 2(C26 H28 F3 N7 O2) FORMUL 4 PEG C4 H10 O3 FORMUL 6 PG4 C8 H18 O5 FORMUL 7 HOH *4(H2 O) HELIX 1 AA1 ALA A 384 ARG A 389 1 6 HELIX 2 AA2 HIS A 431 VAL A 443 1 13 HELIX 3 AA3 ASP A 472 ASN A 481 1 10 HELIX 4 AA4 TPO A 484 LEU A 505 1 22 HELIX 5 AA5 LYS A 513 GLU A 515 5 3 HELIX 6 AA6 THR A 550 VAL A 554 5 5 HELIX 7 AA7 ALA A 555 GLU A 561 1 7 HELIX 8 AA8 LYS A 567 GLY A 583 1 17 HELIX 9 AA9 GLU A 595 GLY A 604 1 10 HELIX 10 AB1 SER A 617 LEU A 628 1 12 HELIX 11 AB2 SER A 637 GLU A 643 1 7 HELIX 12 AB3 PRO B 383 ARG B 389 1 7 HELIX 13 AB4 LYS B 429 VAL B 443 1 15 HELIX 14 AB5 ASP B 472 ASN B 481 1 10 HELIX 15 AB6 THR B 484 LEU B 505 1 22 HELIX 16 AB7 LYS B 513 GLU B 515 5 3 HELIX 17 AB8 THR B 550 VAL B 554 5 5 HELIX 18 AB9 ALA B 555 ALA B 560 1 6 HELIX 19 AC1 LYS B 567 GLY B 583 1 17 HELIX 20 AC2 GLU B 595 GLY B 604 1 10 HELIX 21 AC3 PRO B 611 ASN B 615 5 5 HELIX 22 AC4 SER B 617 LEU B 628 1 12 HELIX 23 AC5 SER B 637 GLU B 643 1 7 SHEET 1 AA1 5 TYR A 390 THR A 395 0 SHEET 2 AA1 5 VAL A 403 GLU A 409 -1 O GLU A 406 N GLY A 393 SHEET 3 AA1 5 GLU A 415 ILE A 421 -1 O TYR A 416 N CYS A 407 SHEET 4 AA1 5 LEU A 461 GLU A 466 -1 O LEU A 461 N ILE A 421 SHEET 5 AA1 5 LEU A 451 ASP A 456 -1 N ILE A 452 O VAL A 464 SHEET 1 AA2 2 ILE A 507 VAL A 508 0 SHEET 2 AA2 2 THR A 538 ILE A 539 -1 O THR A 538 N VAL A 508 SHEET 1 AA3 2 LEU A 517 VAL A 519 0 SHEET 2 AA3 2 LEU A 529 LEU A 531 -1 O LYS A 530 N LEU A 518 SHEET 1 AA4 5 TYR B 390 THR B 395 0 SHEET 2 AA4 5 ALA B 402 GLU B 409 -1 O GLU B 406 N GLY B 393 SHEET 3 AA4 5 GLU B 415 LYS B 422 -1 O LEU B 418 N LYS B 405 SHEET 4 AA4 5 GLU B 460 MET B 465 -1 O LEU B 463 N LYS B 419 SHEET 5 AA4 5 LEU B 451 ASP B 456 -1 N GLU B 453 O VAL B 464 SHEET 1 AA5 2 ILE B 507 VAL B 508 0 SHEET 2 AA5 2 THR B 538 ILE B 539 -1 O THR B 538 N VAL B 508 SHEET 1 AA6 2 LEU B 517 GLU B 521 0 SHEET 2 AA6 2 LYS B 527 LEU B 531 -1 O SER B 528 N TYR B 520 LINK C TYR A 483 N TPO A 484 1555 1555 1.33 LINK C TPO A 484 N GLU A 485 1555 1555 1.33 CISPEP 1 SER A 610 PRO A 611 0 5.22 CISPEP 2 SER B 610 PRO B 611 0 4.40 CRYST1 143.950 61.714 65.312 90.00 103.04 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006947 0.000000 0.001609 0.00000 SCALE2 0.000000 0.016204 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015717 0.00000